[go: up one dir, main page]

AU2001255268A1 - Inhibition of cytokine generation - Google Patents

Inhibition of cytokine generation

Info

Publication number
AU2001255268A1
AU2001255268A1 AU2001255268A AU5526801A AU2001255268A1 AU 2001255268 A1 AU2001255268 A1 AU 2001255268A1 AU 2001255268 A AU2001255268 A AU 2001255268A AU 5526801 A AU5526801 A AU 5526801A AU 2001255268 A1 AU2001255268 A1 AU 2001255268A1
Authority
AU
Australia
Prior art keywords
inhibition
cytokine generation
cytokine
generation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001255268A
Other languages
English (en)
Inventor
William Kreutner
Robert P. Schleimer
John Schroeder
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of AU2001255268A1 publication Critical patent/AU2001255268A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
AU2001255268A 2000-04-07 2001-04-05 Inhibition of cytokine generation Abandoned AU2001255268A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19601600P 2000-04-07 2000-04-07
US60196016 2000-04-07
PCT/US2001/011474 WO2001076600A2 (fr) 2000-04-07 2001-04-05 Inhibition de la production de cytokines

Publications (1)

Publication Number Publication Date
AU2001255268A1 true AU2001255268A1 (en) 2001-10-23

Family

ID=22723784

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001255268A Abandoned AU2001255268A1 (en) 2000-04-07 2001-04-05 Inhibition of cytokine generation

Country Status (6)

Country Link
EP (1) EP1267870A2 (fr)
JP (1) JP2003530351A (fr)
AU (1) AU2001255268A1 (fr)
CA (1) CA2405413A1 (fr)
MX (1) MXPA02009821A (fr)
WO (1) WO2001076600A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200522932A (en) * 2003-09-15 2005-07-16 Combinatorx Inc Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5595997A (en) * 1994-12-30 1997-01-21 Sepracor Inc. Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine

Also Published As

Publication number Publication date
MXPA02009821A (es) 2003-03-27
WO2001076600A2 (fr) 2001-10-18
CA2405413A1 (fr) 2001-10-18
EP1267870A2 (fr) 2003-01-02
WO2001076600A3 (fr) 2002-06-27
JP2003530351A (ja) 2003-10-14

Similar Documents

Publication Publication Date Title
AU2001273358A1 (en) An estimate of efficiency using acceleration - heart rate ratio
AU2001258771A1 (en) -secretase inhibitors
AU2001264256A1 (en) Plaster
AU2001294912A1 (en) Hydroxyesters of 7-desmethylrapamycin
AU2001291859A1 (en) Use of copolycarbonates
AU2001276931A1 (en) Elbow prosthesis
AU2000269903A1 (en) Mechanical connection of panels
AU2637801A (en) Methods of forming semiconductor structures
AU2001252679A1 (en) Plaster
AU2002220241A1 (en) Parb inhibitors
AU2002367129A1 (en) Organ fibrosis inhibitors
AU2001277003A1 (en) Antisense inhibition of her-3 expression
AU2002222627A1 (en) Tak1 inhibitors
AU2001255090A1 (en) Cdk inhibitors having 3-hydroxychromen-4-one structure
AU2001244562A1 (en) Neovascularization inhibitors
AU2001293048A1 (en) Antiviral compositions and methods of use
AU2001284763A1 (en) Preparation of risperidone
AU2001245741A1 (en) Antisense inhibition of adam10 expression
AUPQ629000A0 (en) Inhibition of fungi
AU2002222933A1 (en) Inhibitors of factor xa
AU2001262533A1 (en) Foamed ceramics
AU2001245950A1 (en) Preparation of deoxynucleosides
AU2001255268A1 (en) Inhibition of cytokine generation
AU2001268853A1 (en) Biocatalyst inhibitors
AU2001272490A1 (en) Use of galiella lactone